Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Rani Therapeutics Holdings (RANI) Other Gross PP&E Adjustments (2020 - 2026)

Rani Therapeutics Holdings' Other Gross PP&E Adjustments history spans 7 years, with the latest figure at -$4.4 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 15.46% to -$4.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$4.4 million, a 15.46% increase, with the full-year FY2025 number at -$10.5 million, down 63.14% from a year prior.
  • Other Gross PP&E Adjustments came in at -$4.4 million for Q1 2026, up from -$10.5 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $2.6 million in Q4 2022, with the low at -$10.5 million in Q4 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$3.7 million across 5 years, with a median of -$4.4 million in 2026.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 697.22% in 2022 and later plummeted 3627.33% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $2.6 million in 2022, then crashed by 106.68% to -$172000.0 in 2023, then crashed by 3627.33% to -$6.4 million in 2024, then plummeted by 63.14% to -$10.5 million in 2025, then soared by 57.8% to -$4.4 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for RANI at -$4.4 million in Q1 2026, -$10.5 million in Q4 2025, and -$5.4 million in Q3 2025.